市場調查報告書
商品編碼
1059562

全球支架增長機會/行業預測(2021-2030):按產品/材料/最終用戶

Stents Market by Product, Material, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

出版日期: | 出版商: Allied Market Research | 英文 251 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球支架市場預計將從 2020 年的 117.494 億美元增長到預測期內的 5.6% 的複合年增長率,並在 2030 年增長到 197.675 億美元。

全球支架市場的增長導致心血管疾病的患病率顯著增加,政府加大了開發有效治療的力度,血管成形術的數量增加,以及醫療領域的技術進步。老年人口是主要因素。增加支架批准的數量和採用各種公司的先進支架製造戰略也是全球支架市場的主要驅動力。

本報告調查全球支架市場,定義和概述市場,分析市場影響因素,市場規模變化/預測,產品/材料/支架/最終用戶/地區/主要國家等。它總結了細分市場品類、競爭環境、大公司概況等。

目錄

第一章介紹

第2章執行摘要

第三章市場概述

  • 市場定義和範圍
  • 主要調查結果
  • 波特五力分析
  • 各大公司的定位
  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 影響分析
  • COVID-19:影響分析

第 4 章支架市場:按產品分類

  • 概覽
  • 主要市場趨勢/增長因素/機會
  • 市場規模/預測:按地區
  • 市場分析:按國家/地區
  • 冠狀動脈支架
    • 藥物洗脫支架 (DES)
    • 裸金屬冠狀動脈支架
    • 生物可吸收支架
  • 周邊支架
    • 髂骨支架
    • 大腿膕支架
    • 腎臟及相關支架
    • 頸動脈支架
  • 支架相關植入物
    • 合成嫁接
    • 腔靜脈過濾器

第 5 章支架市場:按材料

  • 概覽
  • 金屬生物材料
  • 高分子生物材料
  • 天然生物材料
    • 主要市場趨勢/增長因素/機會
    • 市場規模/預測:按地區
    • 市場分析:按國家/地區

第 6 章支架市場:按最終用戶

  • 概覽
  • 醫院
  • 門診手術中心
  • 其他
    • 主要市場趨勢/增長因素/機會
    • 市場規模/預測:按地區
    • 市場分析:按國家/地區

第 7 章支架市場:按地區

  • 概覽
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢/增長因素/機會
    • 支架市場:按產品分類
    • 支架市場:按材料分類
    • 支架市場:按最終用戶分類
    • 市場規模/預測:按國家/地區

第 8 章公司簡介

  • ABBOTT LABORATORIES
  • B. BRAUN MELSUNGEN AG
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORPORATION
  • BECTON, DICKINSON AND COMPANY
  • ELIXIR MEDICAL CORPORATION
  • MEDTRONIC PLC
  • MICROPORT SCIENTIFIC CORPORATION
  • REVA MEDICAL, INC.
  • TERUMO CORPORATION
目錄
Product Code: LI_161603 / A01278

The global stents market was valued at $11,749.4 million in 2020, and is estimated to reach $19,767.5 million by 2030, growing at a CAGR of 5.6% from 2021 to 2030.

A stents is a medical device, which is inserted into internal duct of the body for expanding blood vessels and preventing vessels from blockage. Stents act by expanding vessels or internal duct for clearing the blockage caused due to deposition of plague. Natural stents are designed in such a way that after eluting a drug, the stents get dissolved within the body at a certain interval of time.

Growth of the global stents market is majorly driven by alarming increase in prevalence of cardiovascular disease; rise in government initiatives for development of effective treatment procedure; increase in number of angioplasty surgery; advancements in technology in the healthcare sector; and rise in geriatric population. For instance, according to the Centers for Disease Control and Prevention, in 2019, approximately 14.2% people above the age of 45 years were reported to be diagnosed with coronary artery disease across the globe. Moreover, in 2021, the Government of India announced a Scheme for "Promotion of Medical Device Parks". It is an initiative taken by government to support the medical devices. Furthermore, in November 2019, the American College of Cardiology, announced that a physician conduct around 1.2 million angioplasties in the U.S., in a year. Thus, an increase in number of angioplasty surgery and rise in funds by governments and private organizations for development of medical devices is expected to propel growth of the market.

Increase in number of approval of stents and adoption of different strategy of market players in manufacturing of advanced stents are the major factors that drive the global stents market. Arterius Limited, in April 2019, collaborated with Translational Biomedical Research Centre for development of new bioabsorbable stents to get accurate and reliable results. Moreover, increase in incidences of chronic diseases such as diabetics and hypertension significantly contributes to the market growth. Rise in demand for stents acts a key driving force for expansion of the global market. Further, in March 2021, Elixir Medical Corporation, a developer of drug-eluting cardiovascular devices, announced the result of the INFINITY SWEDEHEART randomized controlled trial (RCT) of DynamX Coronary Bioadaptor system. The result states that dynamx Coronary bioadaptor has no target of myocardial infarction or thrombosis through 24 months.

For instance, in April 2021, the MicroPort Scientific Corporation launched Castor Branched Stents-Graft system, which is used for treatment of aortic arch repair by minimally invasive surgical procedure. Thus, advancements in technology for development of stents in emerging nations are anticipated to provide lucrative opportunities for the market expansion.

However, high cost of stents used for treatment of vascular blockage is anticipated to hinder the market growth. Rise in the healthcare sector for management of coronary and peripheral artery disease, rise in per capital income, and rise in adoption of stents by patients and physicians augments growth of the market. This has further encouraged many key players to enter emerging markets, thus offering lucrative growth opportunities for the stents market.

The global stents market is segmented into product, material, end user, and region. By product, the market is categorized into coronary stents, peripheral stents, and stents-related implant. Depending on material, it is fragmented into metallic biomaterials, polymer biomaterials and natural biomaterials. On the basis of end user, it is divided into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global stents market are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & CO. KG., Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc., Microport Scientific Corporation, Reva Medical, Inc., and Terumo Corporation.

Some of the major companies that operate in the global stents market are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & CO. KG., Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc., Microport Scientific Corporation, Reva Medical, Inc., and Terumo Corporation.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global stents market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global stents market.

KEY MARKET SEGMENTS

By Product

  • Coronary Stents
  • Drug-eluting stents (DES)
  • Bare-metal coronary stents
  • Bioabsorbable stents
  • Peripheral Stents
  • Iliac stent
  • Femoral-popliteal stents
  • Renal & related stents
  • Carotid stents
  • Stent Related Implant
  • Synthetic grafts
  • Vena cava filters

By Material

  • Metallic Biomaterial
  • Polymer Biomaterial
  • Natural Biomaterial

By End User

  • Hospital
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & CO. KG.
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Elixir Medical Corporation
  • Medtronic Plc.
  • Microport Scientific Corporation
  • Reva Medical, Inc.
  • Terumo Corporation

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in prevalence of heart diseases and rise in geriatric population
      • 3.5.1.2.Increase in demand for angioplasty
      • 3.5.1.3.Increase in number of approvals for stents
    • 3.5.2.Restraint
      • 3.5.2.1.High cost of procedures associated with stents
    • 3.5.3.Opportunity
      • 3.5.3.1.Increase in R&D and advancements in technology
      • 3.5.3.2.Increase in healthcare expenditure
    • 3.5.4.Impact analysis
  • 3.6.Impact analysis of COVID-19 on the stents market

CHAPTER 4:STENTS MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Coronary stents
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Coronary stents, by type
      • 4.2.2.1.Market size and forecast
      • 4.2.2.2.Drug-eluting stents (DES)
      • 4.2.2.2.1.Market size and forecast
      • 4.2.2.3.Bare-metal coronary stents
      • 4.2.2.3.1.Market size and forecast
      • 4.2.2.4.Bioabsorbable stents
      • 4.2.2.4.1.Market size and forecast
    • 4.2.3.Market size and forecast, by region
    • 4.2.4.Market analysis, by country
  • 4.3.Peripheral stents
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Peripheral stents, by type
      • 4.3.2.1.Market size and forecast
      • 4.3.2.2.Iliac stents
      • 4.3.2.2.1.Market size and forecast
      • 4.3.2.3.Femoral-popliteal stents
      • 4.3.2.3.1.Market size and forecast
      • 4.3.2.4.Renal & related stents
      • 4.3.2.4.1.Market size and forecast
      • 4.3.2.5.Carotid stents
      • 4.3.2.5.1.Market size and forecast
    • 4.3.3.Market size and forecast, by region
    • 4.3.4.Market analysis, by country
  • 4.4.Stents-related implant
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Stents related implant, by type
      • 4.4.2.1.Market size and forecast
      • 4.4.2.2.Synthetic grafts
      • 4.4.2.2.1.Market size and forecast
      • 4.4.2.3.Vena cava filters
      • 4.4.2.3.1.Market size and forecast
    • 4.4.3.Market size and forecast, by region
    • 4.4.4.Market analysis, by country

CHAPTER 5:STENTS MARKET, BY MATERIAL

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Metallic biomaterials
    • 5.2.1.Key market trends, growth factors, and opportunities
    • 5.2.2.Market size and forecast, by region
    • 5.2.3.Market analysis, by country
  • 5.3.Polymer biomaterials
    • 5.3.1.Key market trends, growth factors, and opportunities
    • 5.3.2.Market size and forecast, by region
    • 5.3.3.Market analysis, by country
  • 5.4.Natural biomaterials
    • 5.4.1.Key market trends, growth factors, and opportunities
    • 5.4.2.Market size and forecast, by region
    • 5.4.3.Market analysis, by country

CHAPTER 6:STENTS MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Hospitals
    • 6.2.1.Key market trends, growth factors, and opportunities
    • 6.2.2.Market size and forecast, by region
    • 6.2.3.Market analysis, by country
  • 6.3.Ambulatory Surgical Center
    • 6.3.1.Key market trends, growth factors, and opportunities
    • 6.3.2.Market size and forecast, by region
    • 6.3.3.Market analysis, by country
  • 6.4.Others
    • 6.4.1.Key market trends, growth factors, and opportunities
    • 6.4.2.Market size and forecast, by region
    • 6.4.3.Market analysis, by country

CHAPTER 7:STENTS MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.North America Stents market, by product
    • 7.2.3.North America Stents market, by material
    • 7.2.4.North America Stents market, by end user
    • 7.2.5.Market size and forecast, by country
      • 7.2.5.1.U.S.
      • 7.2.5.1.1.U.S. Stents market, by product
      • 7.2.5.1.2.U.S. Stents market, by material
      • 7.2.5.1.3.U.S. Stents market, by end user
      • 7.2.5.2.Canada
      • 7.2.5.2.1.Canada Stents market, by product
      • 7.2.5.2.2.Canada Stents market, by material
      • 7.2.5.2.3.Canada Stents market, by end user
      • 7.2.5.3.Mexico
      • 7.2.5.3.1.Mexico Stents market, by product
      • 7.2.5.3.2.Mexico Stents market, by material
      • 7.2.5.3.3.Mexico Stents market, by end user
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Europe Stents market, by product
    • 7.3.3.Europe Stents market, by material
    • 7.3.4.Europe Stents market, by end user
    • 7.3.5.Market size and forecast, by country
      • 7.3.5.1.Germany
      • 7.3.5.1.1.Germany Stents market, by product
      • 7.3.5.1.2.Germany Stents market, by material
      • 7.3.5.1.3.Germany Stents market, by end user
      • 7.3.5.2.France
      • 7.3.5.2.1.France Stents market, by product
      • 7.3.5.2.2.France Stents market, by material
      • 7.3.5.2.3.France Stents market, by end user
      • 7.3.5.3.UK
      • 7.3.5.3.1.UK Stents market, by product
      • 7.3.5.3.2.UK Stents market, by material
      • 7.3.5.3.3.UK Stents market, by end user
      • 7.3.5.4.Italy
      • 7.3.5.4.1.Italy Stents market, by product
      • 7.3.5.4.2.Italy Stents market, by material
      • 7.3.5.4.3.Italy Stents market, by end user
      • 7.3.5.5.Spain
      • 7.3.5.5.1.Spain Stents market, by product
      • 7.3.5.5.2.Spain Stents market, by material
      • 7.3.5.5.3.Spain Stents market, by end user
      • 7.3.5.6.Rest of Europe
      • 7.3.5.6.1.Rest of Europe Stents market, by product
      • 7.3.5.6.2.Rest of Europe Stents market, by material
      • 7.3.5.6.3.Rest of Europe Stents market, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Asia-Pacific Stents market, by product
    • 7.4.3.Asia-Pacific Stents market, by material
    • 7.4.4.Asia-Pacific Stents market, by end user
    • 7.4.5.Market size and forecast, by country
      • 7.4.5.1.China
      • 7.4.5.1.1.China Stents market, by product
      • 7.4.5.1.2.China Stents market, by material
      • 7.4.5.1.3.China Stents market, by end user
      • 7.4.5.2.Japan
      • 7.4.5.2.1.Japan Stents market, by product
      • 7.4.5.2.2.Japan Stents market, by material
      • 7.4.5.2.3.Japan Stents market, by end user
      • 7.4.5.3.India
      • 7.4.5.3.1.India Stents market, by product
      • 7.4.5.3.2.India Stents market, by material
      • 7.4.5.3.3.India Stents market, by end user
      • 7.4.5.4.Australia
      • 7.4.5.4.1.Australia Stents market, by product
      • 7.4.5.4.2.Australia Stents market, by material
      • 7.4.5.4.3.Australia Stents market, by end user
      • 7.4.5.5.Rest of Asia-Pacific
      • 7.4.5.5.1.Rest of Asia-Pacific Stents market, by product
      • 7.4.5.5.2.Rest of Asia-Pacific Stents market, by material
      • 7.4.5.5.3.Rest of Asia-Pacific Stents market, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.LAMEA Stents market, by product
    • 7.5.3.LAMEA Stents market, by material
    • 7.5.4.LAMEA Stents market, by end user
    • 7.5.5.Market size and forecast, by country
      • 7.5.5.1.Brazil
      • 7.5.5.1.1.Brazil Stents market, by product
      • 7.5.5.1.2.Brazil Stents market, by material
      • 7.5.5.1.3.Brazil Stents market, by end user
      • 7.5.5.2.Saudi Arabia
      • 7.5.5.2.1.Saudi Arabia Stents market, by product
      • 7.5.5.2.2.Saudi Arabia Stents market, by material
      • 7.5.5.2.3.Saudi Arabia Stents market, by end user
      • 7.5.5.3.South Africa
      • 7.5.5.3.1.South Africa Stents market, by product
      • 7.5.5.3.2.South Africa Stents market, by material
      • 7.5.5.3.3.South Africa Stents market, by end user
      • 7.5.5.4.Rest of LAMEA
      • 7.5.5.4.1.Rest of LAMEA Stents market, by product
      • 7.5.5.4.2.Rest of LAMEA Stents market, by material
      • 7.5.5.4.3.Rest of LAMEA Stents market, by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.ABBOTT LABORATORIES
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Business performance
    • 8.1.6.Key strategic moves and developments
  • 8.2.B. BRAUN MELSUNGEN AG
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
    • 8.2.5.Business performance
    • 8.2.6.Key strategic moves and developments
  • 8.3.BIOTRONIK SE & CO. KG
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Key strategic moves and developments
  • 8.4.BOSTON SCIENTIFIC CORPORATION
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
    • 8.4.5.Business performance
    • 8.4.6.Key strategic moves and developments
  • 8.5.BECTON, DICKINSON AND COMPANY
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Business performance
    • 8.5.6.Key strategic moves and developments
  • 8.6.ELIXIR MEDICAL CORPORATION
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
    • 8.6.5.Key strategic moves and developments
  • 8.7.MEDTRONIC PLC
    • 8.7.1.Company overview
    • 8.7.2.Operating business segments
    • 8.7.3.Product portfolio
    • 8.7.4.Business performance
  • 8.8.MICROPORT SCIENTIFIC CORPORATION
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
    • 8.8.6.Key strategic moves and developments
  • 8.9.REVA MEDICAL, INC.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Product portfolio
  • 8.10.TERUMO CORPORATION
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
    • 8.10.6.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 02.STENTS MARKET, BY CORONARY STENTS, 2020-2030 ($MILLION)
  • TABLE 03.STENTS MARKET FOR CORONARY STENTS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 04.STENTS MARKET, BY PERIPHERAL STENTS, 2020-2030 ($MILLION)
  • TABLE 05.STENTS MARKET FOR PERIPHERAL STENTS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 06.STENTS MARKET, BY STENTS-RELATED IMPLANT, 2020-2030 ($MILLION)
  • TABLE 07.STENTS MARKET FOR PERIPHERAL STENTS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 08.STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 09.STENTS MARKET FOR METALLIC BIOMATERIALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 10.STENTS MARKET FOR POLYMER BIOMATERIALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.STENTS MARKET FOR NATURAL BIOMATERIALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12.STENTS MARKET, BY HOSPITAL, 2020-2030 ($MILLION)
  • TABLE 13.STENTS MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14.STENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15.STENTS MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 16.STENTS MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 17.NORTH AMERICA STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 18.NORTH AMERICA STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 19.NORTH AMERICA STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 20.NORTH AMERICA STENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 21.U.S. STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 22.U.S. STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 23.U.S. STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 24.CANADA STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 25.CANADA STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 26.CANADA STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 27.MEXICO STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 28.MEXICO STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 29.MEXICO STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 30.EUROPE STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 31.EUROPE STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 32.EUROPE STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 33.EUROPE STENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 34.GERMANY STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 35.GERMANY STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 36.GERMANY STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 37.FRANCE STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 38.FRANCE STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 39.FRANCE STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 40.UK STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 41.UK STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 42.UK STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 43.ITALY STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 44.ITALY STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 45.ITALY STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 46.SPAIN STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 47.SPAIN STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 48.SPAIN STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 49.REST OF EUROPE STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 50.REST OF EUROPE STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 51.REST OF EUROPE STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 52.ASIA-PACIFIC STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 53.ASIA-PACIFIC STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 54.ASIA-PACIFIC STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 55.ASIA-PACIFIC STENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 56.CHINA STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 57.CHINA STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 58.CHINA STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 59.JAPAN STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 60.JAPAN STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 61.JAPAN STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 62.INDIA STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 63.INDIA STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 64.INDIA STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 65.AUSTRALIA STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 66.AUSTRALIA STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 67.AUSTRALIA STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 68.REST OF ASIA-PACIFIC STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 69.REST OF ASIA-PACIFIC STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 70.REST OF ASIA-PACIFIC STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 71.LAMEA STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 72.LAMEA STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 73.LAMEA STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 74.LAMEA STENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 75.BRAZIL STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 76.BRAZIL STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 77.BRAZIL STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 78.SAUDI ARABIA STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 79.SAUDI ARABIA STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 80.SAUDI ARABIA STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 81.SOUTH AFRICA STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 82.SOUTH AFRICA STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 83.SOUTH AFRICA STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 84.REST OF LAMEA STENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 85.REST OF LAMEA STENTS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 86.REST OF LAMEA STENTS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 87.ABBOTT: COMPANY SNAPSHOT
  • TABLE 88.ABBOTT: OPERATING SEGMENT
  • TABLE 89.ABBOTT: PRODUCT PORTFOLIO
  • TABLE 90.ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91.B. BRAUN: COMPANY SNAPSHOT
  • TABLE 92.B. BRAUN: OERATING SEGMENT
  • TABLE 93.B. BRAUN: PRODUCT PORTFOLIO
  • TABLE 94.B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95.BIOTRONIK: COMPANY SNAPSHOT
  • TABLE 96.BIOTRONIK: OERATING SEGMENT
  • TABLE 97.BIOTRONIK: PRODUCT PORTFOLIO
  • TABLE 98.BIOTRONIK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 100.BOSTON SCIENTIFIC: OERATING SEGMENT
  • TABLE 101.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 102.BOSTON SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103.BD: COMPANY SNAPSHOT
  • TABLE 104.BD: OERATING SEGMENT
  • TABLE 105.BD: PRODUCT PORTFOLIO
  • TABLE 106.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107.ELIXIR MEDICAL: COMPANY SNAPSHOT
  • TABLE 108.ELIXIR MEDICAL: OERATING SEGMENT
  • TABLE 109.ELIXIR MEDICAL: PRODUCT PORTFOLIO
  • TABLE 110.ELIXIR MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 112.MEDTRONIC: OERATING SEGMENT
  • TABLE 113.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 114.MICROPORT: COMPANY SNAPSHOT
  • TABLE 115.MICROPORT: OERATING SEGMENT
  • TABLE 116.MICROPORT: PRODUCT PORTFOLIO
  • TABLE 117.MICROPORT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118.REVA MEDICAL: COMPANY SNAPSHOT
  • TABLE 119.REVA MEDICAL: PRODUCT PORTFOLIO
  • TABLE 120.TERUMO: COMPANY SNAPSHOT
  • TABLE 121.TERUMO: OERATING SEGMENT
  • TABLE 122.TERUMO: PRODUCT PORTFOLIO
  • TABLE 123.TERUMO: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 01.STENTS MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
  • FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 09.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 10.MODERATE INTENSITY OF RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.IMPACT ANALYSIS
  • FIGURE 13.STENTS MARKET BY CORONARY STENTS, 2020-2030 ($MILLION)
  • FIGURE 14.STENTS MARKET BY BARE-METAL CORONARY STENTS, 2020-2030 ($MILLION)
  • FIGURE 15.STENTS MARKET BY BIOABSORBABLE STENTS, 2020-2030 ($MILLION)
  • FIGURE 16.COMPARATIVE ANALYSIS OF STENTS MARKET FOR CORONARY STENTS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 17.STENTS MARKET BY ILIAC STENTS, 2020-2030 ($MILLION)
  • FIGURE 18.STENTS MARKET BY FEMORAL-POPLITEAL STENTS, 2020-2030 ($MILLION)
  • FIGURE 19.STENTS MARKET BY RENAL & RELATED STENTS, 2020-2030 ($MILLION)
  • FIGURE 20.STENTS MARKET BY CAROTID STENTS, 2020-2030 ($MILLION)
  • FIGURE 21.COMPARATIVE ANALYSIS OF STENTS MARKET FOR PERIPHERAL STENTS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 22.STENTS MARKET BY SYNTHETIC GRAFTS, 2020-2030 ($MILLION)
  • FIGURE 23.STENTS MARKET BY VENA CAVA FILTERS, 2020-2030 ($MILLION)
  • FIGURE 24.COMPARATIVE ANALYSIS OF STENTS MARKET FOR PERIPHERAL STENTS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 25.COMPARATIVE ANALYSIS OF STENTS MARKET FOR METALLIC BIOMATERIALS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 26.COMPARATIVE ANALYSIS OF STENTS MARKET FOR POLYMER BIOMATERIALS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 27.COMPARATIVE ANALYSIS OF STENTS MARKET FOR NATURAL BIOMATERIALS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 28.COMPARATIVE ANALYSIS OF STENTS MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 29.COMPARATIVE ANALYSIS OF STENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 30.COMPARATIVE ANALYSIS OF STENTS MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 31.ABBOTT: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 32.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 33.ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 34.B. BRAUN: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 35.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 36.B. BRAUN: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 37.BOSTON SCIENTIFIC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 38.BOSTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 39.BOSTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 40.BD: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 41.BD: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 42.BD: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 43.MEDTRONIC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 44.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 45.MEDTRONIC: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 46.MICROPORT: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 47.MICROPORT: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 48.MICROPORT: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 49.TERUMO: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 50.TERUMO: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 51.TERUMO: REVENUE SHARE, BY REGION, 2020 (%)